AgBiome Receives U.S. EPA Approval for New Esendo Fungicide

Esendo fungicide is the latest in AgBiome’s lineup of microbial-based solutions and the first of its proprietary Connate portfolio to receive approval from the U.S. EPA. AgBiome, Inc., a leader in developing innovative products from the Earth’s microbial communities, is the developer of both Howler fungicide and recently EPA-approved Theia fungicide.

“We are thrilled to introduce Esendo fungicide to the market,” said Adam Burnhams, chief commercial officer at AgBiome. “It is our mission to create environmentally mindful solutions for producers that allow for effective resistance management and promote healthier crops.”

Advertisement

This broad-spectrum fungicide provides powerful systemic and protectant activity, allowing for excellent control and resistance management for key foliar diseases such as rust and alternaria in high-value fruit, vegetable, and tree nut crops. Esendo fungicide’s premixed formula combines the synthetic fungicide azoxystrobin with the active biological ingredient in AgBiome’s premier biological product, Howler fungicide.

Esendo fungicide is the first product in AgBiome’s Connate portfolio which contains proprietary mixtures of synthetic and biological actives, which allow for broad-spectrum control and preservation of key active ingredients. These mixtures increase efficacy as they expand the breadth of disease coverage the products provide.

“As the first of our Connate line, Esendo fungicide is an exciting and important development for the market,” said Gustavo Marcos, senior product manager at AgBiome. “Not only will it provide significant protection for a variety of crops covering a wide disease range, but it will also optimize the chemical load introduced into the environment and help producers extend the life cycle of important synthetic ingredients.”

Top Articles
Russian Agrochemicals Market Update: How Companies Are Responding to AI Shortage, Regulation Changes

State registrations are now pending, with Esendo fungicide’s commercial availability expected in early 2023.

Hide picture